Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate

Yajuan Li; Ying Yuan; Kun Tao; Xin Wang; Qing Xiao; Zhenglan Huang; Liang Zhong; Weixi Cao; Jianping Wen; Wenli Feng

doi:10.1371/journal.pone.0061858

Loading metrics

Open Access

Peer-reviewed

Research Article

Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate

Yajuan Li ,

Contributed equally to this work with: Yajuan Li, Ying Yuan

Affiliation Key Laboratory of Laboratory Medical Diagnostics and Department of Clinical Hematology Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China
⨯
Ying Yuan ,

Contributed equally to this work with: Yajuan Li, Ying Yuan

Affiliation Department of General Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
⨯
Kun Tao,

Affiliation Department of Immunology, Chongqing Medical University, Chongqing, China
⨯
Xin Wang,

Affiliation Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
⨯
Qing Xiao,

Affiliation Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
⨯
Zhenglan Huang,

Affiliation Key Laboratory of Laboratory Medical Diagnostics and Department of Clinical Hematology Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China
⨯
Liang Zhong,

Affiliation Key Laboratory of Laboratory Medical Diagnostics and Department of Clinical Hematology Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China
⨯
Weixi Cao,

Affiliation Key Laboratory of Laboratory Medical Diagnostics and Department of Clinical Hematology Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China
⨯
Jianping Wen,

Affiliation Department of Pathology and Molecular Medicine, McMaster University, Ontario, Canada
⨯
Wenli Feng

* E-mail: fengwlcqmu@sina.com.

Affiliation Key Laboratory of Laboratory Medical Diagnostics and Department of Clinical Hematology Designated by the Ministry of Education, Chongqing Medical University, Chongqing, China
⨯

Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate

Yajuan Li,
Ying Yuan,
Kun Tao,
Xin Wang,
Qing Xiao,
Zhenglan Huang,
Liang Zhong,
Weixi Cao,
Jianping Wen,
Wenli Feng

Published: April 16, 2013
https://doi.org/10.1371/journal.pone.0061858

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
G1 phase
Is the Subject Area "G1 phase" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
MTT assay
Is the Subject Area "MTT assay" applicable to this article?

Thanks for your feedback.
Point mutation
Is the Subject Area "Point mutation" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.
Post-transcriptional gene regulation
Is the Subject Area "Post-transcriptional gene regulation" applicable to this article?

Thanks for your feedback.